Trial Profile
Relation to CSF biomarkers in patients with Alzheimer's disease tauopathy measured with [18F]-AV-1451
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Aug 2017
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 29 Aug 2017 New trial record
- 20 Jul 2017 Results presented at the Alzheimer's Association International Conference 2017